These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31931804)

  • 1. N-acetyl-L-cysteine reduces Leishmania amazonensis-induced inflammation in BALB/c mice.
    Crupi R; Gugliandolo E; Siracusa R; Impellizzeri D; Cordaro M; Di Paola R; Britti D; Cuzzocrea S
    BMC Vet Res; 2020 Jan; 16(1):13. PubMed ID: 31931804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania (L). amazonensis induces hyperalgesia in balb/c mice: Contribution of endogenous spinal cord TNFα and NFκB activation.
    Borghi SM; Fattori V; Ruiz-Miyazawa KW; Miranda-Sapla MM; Casagrande R; Pinge-Filho P; Pavanelli WR; Verri WA
    Chem Biol Interact; 2017 Apr; 268():1-12. PubMed ID: 28219639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyl-cysteine inhibits liver oxidative stress markers in BALB/c mice infected with Leishmania amazonensis.
    Gasparotto J; Kunzler A; Senger MR; Souza CD; Simone SG; Bortolin RC; Somensi N; Dal-Pizzol F; Moreira JC; Abreu-Silva AL; Calabrese KD; Silva FP; Gelain DP
    Mem Inst Oswaldo Cruz; 2017 Feb; 112(2):146-154. PubMed ID: 28177049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucantime reduces mechanical hyperalgesia in cutaneous leishmaniasis and complete Freund's adjuvant models of chronic inflammatory pain.
    da Silva SS; Mizokami SS; Fanti JR; Costa IN; Bordignon J; Felipe I; Pavanelli WR; Verri WA; Conchon Costa I
    J Pharm Pharmacol; 2018 Jun; 70(6):768-777. PubMed ID: 29532470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of spinal cord glial cells to L. amazonensis experimental infection-induced pain in BALB/c mice.
    Borghi SM; Fattori V; Pinho-Ribeiro FA; Domiciano TP; Miranda-Sapla MM; Zaninelli TH; Casagrande R; Pinge-Filho P; Pavanelli WR; Alves-Filho JC; Cunha FQ; Cunha TM; Verri WA
    J Neuroinflammation; 2019 May; 16(1):113. PubMed ID: 31138231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetyl-L: -cysteine reduces the parasitism of BALB/c mice infected with Leishmania amazonensis.
    Monteiro MC; Marques FC; Blazius RD; Santos da Silva O; de Queiroz Cunha F; Bento DB; Torres Romão PR
    Parasitol Res; 2008 Mar; 102(4):801-3. PubMed ID: 18094999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propolis reduces Leishmania amazonensis-induced inflammation in the liver of BALB/c mice.
    da Silva SS; Mizokami SS; Fanti JR; Miranda MM; Kawakami NY; Teixeira FH; Araújo EJ; Panis C; Watanabe MA; Sforcin JM; Pavanelli WR; Verri WA; Felipe I; Conchon-Costa I
    Parasitol Res; 2016 Apr; 115(4):1557-66. PubMed ID: 26711452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An 8-hydroxyquinoline-containing polymeric micelle system is effective for the treatment of murine tegumentary leishmaniasis.
    Lage LM; Barichello JM; Lage DP; Mendonça DV; Carvalho AM; Rodrigues MR; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Coelho EA; Duarte MC
    Parasitol Res; 2016 Nov; 115(11):4083-4095. PubMed ID: 27365053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous leishmaniasis and visceral leishmaniasis.
    Al-Abdely HM; Graybill JR; Bocanegra R; Najvar L; Montalbo E; Regen SL; Melby PC
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2542-8. PubMed ID: 9756753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interleukin-4 and prostaglandin E2 in Leishmania amazonensis infection of BALB/c mice.
    Guimarães ET; Santos LA; Ribeiro dos Santos R; Teixeira MM; dos Santos WL; Soares MB
    Microbes Infect; 2006 Apr; 8(5):1219-26. PubMed ID: 16531090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased tau phosphorylation and receptor for advanced glycation endproducts (RAGE) in the brain of mice infected with Leishmania amazonensis.
    Gasparotto J; Senger MR; Kunzler A; Degrossoli A; de Simone SG; Bortolin RC; Somensi N; Girardi CS; de Souza Cda S; Calabrese Kda S; Dal-Pizzol F; Moreira JC; Silva FP; Gelain DP
    Brain Behav Immun; 2015 Jan; 43():37-45. PubMed ID: 25014011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological outcome of Leishmania major-infected BALB/c mice is improved by oral treatment with N-acetyl-l-cysteine.
    Rocha-Vieira E; Ferreira E; Vianna P; De Faria DR; Gaze ST; Dutra WO; Gollob KJ
    Immunology; 2003 Mar; 108(3):401-8. PubMed ID: 12603607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl thiosemicarbazones: In vitro and immunomodulatory activities against L. amazonensis.
    da Silva AC; Dos Santos TAR; da Silva IVB; de Oliveira MVG; Moreira DRM; Leite ACL; Pereira VRA
    Exp Parasitol; 2017 Jun; 177():57-65. PubMed ID: 28433563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
    Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
    Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis.
    Padigel UM; Alexander J; Farrell JP
    J Immunol; 2003 Oct; 171(7):3705-10. PubMed ID: 14500669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A standardized intraperitoneal Glucantime™ for experimental treatment of cutaneous leishmaniasis caused by Leishmania amazonensis in BALB/c mice.
    Brustolin AÁ; Franzói NM; Ramos-Milaré ÁCFH; Tanoshi CA; Mota CA; Demarchi IG; Lonardoni MVC; Verzignassi Silveira TG
    Exp Parasitol; 2022; 236-237():108259. PubMed ID: 35427563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
    Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
    Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
    Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nanoemulsions prepared with essential oils of copaiba- and andiroba against Leishmania infantum and Leishmania amazonensis infections.
    Dhorm Pimentel de Moraes AR; Tavares GD; Soares Rocha FJ; de Paula E; Giorgio S
    Exp Parasitol; 2018 Apr; 187():12-21. PubMed ID: 29518448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis.
    Pinto EF; de Mello Cortezia M; Rossi-Bergmann B
    Vaccine; 2003 Sep; 21(25-26):3534-41. PubMed ID: 12922080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.